Target intelligence / Profile preview

Long non-coding RNA (lncRNA) (lncRNA)

Target
lncRNA
Molecular classification
Non-coding RNA, Long non-coding RNA
01

Overview

Long non-coding RNAs (lncRNAs) are a diverse class of non-protein-coding transcripts longer than 200 nucleotides that play critical roles in regulating gene expression in cardiac cells, particularly through epigenetic mechanisms such as chromatin modification, histone methylation, and interactions with transcription factors or microRNAs. They are classified by genomic location (e.g., intergenic, antisense, enhancer-associated) or function (e.g., decoy, guide, scaffold), influencing cardiac homeostasis and pathological remodeling. In hypertrophic cardiomyopathy and heart failure, specific lncRNAs like Mhrt, Chast, and HOTAIR are dysregulated: Mhrt protects against hypertrophy by counteracting Brg1-HDAC repressor complexes at the MYH7 locus, while others like Chrf promote hypertrophy by sponging miRNAs such as miR-489. LncRNA expression profiles distinguish failing hearts from healthy ones and respond to interventions like LV assist devices, highlighting their potential as dynamic markers of disease progression and reverse remodeling. Although no approved drugs directly target lncRNAs, their conserved roles and tissue-specificity position them as promising therapeutic targets for modulating hypertrophic pathways without broad off-target effects.

Other names
LncRNAnon-coding RNAncRNA
02

Biological functions

Chromatin modificationGene expression regulationSignal transductionTranscriptional regulationEpigenetic regulation
03

Disease associations

Cardiovascular disease

Beyond the preview

Go deeper on Long non-coding RNA (lncRNA) (lncRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA (lncRNA) (lncRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call